RxDoctor Payments Data

Jessica Machue, MD

Hospitalist · Grayling, MINPI 1255750550

Payments from drug & device makers

$411in general payments, 2019–2025

Across 24 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$137
  • Exact Sciences$56
  • Lilly USA, LLC$46
  • Novo Nordisk$33
  • AstraZeneca$29
  • E.r. Squibb & Sons, L.L.C.$28
  • plus $81 from 5 others

What the payments were for

  • Food & beverage$411100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$411 in reported general payments places this provider in the 75th percentile of 342 hospitalist providers in Michigan.

See all hospitalist providers in Michigan

Medicare billing

Part B allowed, 2024
$8,593
Medicare patients
35
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin55$59,984
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$57,976
EliquisApixaban41$51,913
OzempicSemaglutide33$40,983
XareltoRivaroxaban22$29,259
JanuviaSitagliptin Phosphate21$21,373
TrulicityDulaglutide15$18,770
MounjaroTirzepatide16$17,023
Stiolto RespimatTiotropium Br/Olodaterol Hcl20$9,265
Spiriva HandihalerTiotropium Bromide11$9,222
Aimovig AutoinjectorErenumab-Aooe12$8,149
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$6,535
Tresiba Flextouch U-100Insulin Degludec12$6,092
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,529
Qvar RedihalerBeclomethasone Dipropionate17$4,683

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$16$69,24975 claims
GSKTrelegy Ellipta, Anoro Ellipta$15$63,50680 claims
Novo NordiskOzempic$33$40,98333 claims
Lilly USA, LLCTrulicity, Mounjaro$46$35,79331 claims
AstraZenecaPulmicort Flexhaler$29$2,27612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 342 hospitalist providers in Michigan.

Other hospitalist in Grayling

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →